作者
Manisha H. Shah,Whitney Goldner,Þorvarður R. Hálfdánarson,Emily K. Bergsland,Jordan Berlin,Daniel M. Halperin,Jennifer A. Chan,Matthew H. Kulke,Al B. Benson,Lawrence S. Blaszkowsky,Jennifer R. Eads,Paul F. Engstrom,Paul T. Fanta,Thomas J. Giordano,Jin He,Martin J. Heslin,Gregory P. Kalemkerian,Fouad Kandeel,Sajid Khan,Wajih Zaheer Kidwai,Pamela L. Kunz,Boris W. Kuvshinoff,Christopher H. Lieu,Venu G. Pillarisetty,Leonard B. Saltz,Julie Ann Sosa,Jonathan Strosberg,Craig A. Sussman,Nikolaos A. Trikalinos,N. Uboha,Jonathan Whisenant,Terence Z. Wong,James C. Yao,Jennifer L. Burns,Ndiya Ogba,Griselda Zuccarino-Catania
摘要
The NCCN Guidelines for Neuroendocrine and Adrenal Tumors provide recommendations for the management of adult patients with neuroendocrine tumors (NETs), adrenal gland tumors, pheochromocytomas, and paragangliomas. Management of NETs relies heavily on the site of the primary NET. These NCCN Guidelines Insights summarize the management options and the 2018 updates to the guidelines for locoregional advanced disease, and/or distant metastasis originating from gastrointestinal tract, bronchopulmonary, and thymus primary NETs.